Form4insider filings, from the source

SEC Form 4 · accession 0001127602-17-009394

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Pablo Lapuerta
Officer — EVP and CMO
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2017M2,500—A18,266D
Common StockF1Feb 28, 2017M2,822—A21,088D
Common StockF1Feb 28, 2017M4,550—A25,638D
Common StockF1Feb 28, 2017M4,227—A29,865D
Common StockFeb 28, 2017F5,252$16.45D24,613D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 28, 2017M2,500D——Common Stock2,5000D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 28, 2017M2,822D——Common Stock2,8222,821D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 28, 2017M4,550D——Common Stock4,5509,100D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 28, 2017M4,227D——Common Stock4,22712,683D

Explanation of responses